ALPANSEAlpa Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 27 Sept · 16:12 IST

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alpa Laboratories has informed the stock exchanges that its trading window will be closed from October 1, 2025 until 48 hours after the company declares its unaudited financial results for the quarter ending September 30, 2025. This is a standard compliance measure required under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, directors, key managerial personnel, and other designated insiders are prohibited from trading in the company's shares. The closure is typically triggered ahead of a quarterly results announcement to prevent any potential insider trading.

Likely market impact

This is a routine regulatory filing with no material impact on the business or stock price. However, it signals that the company's Q2 FY26 results announcement is likely due in the coming weeks, which investors should watch for.